Composition, form of production and packaging
? Eye gel is colorless or light yellow in color.
1 g
carbomer 980 2 mg
Excipients: sorbitol - 40 mg, cetrimide - 0.1 mg, sodium hydroxide - 0.83 mg, disodium edetate - 0.0375 mg, water d / and - 957.0325 mg.
10 g - aluminum tubes (1) with a polyethylene tip - packs cardboard.
10 g - aluminum tubes (3) with a polyethylene tip - packs cardboard.
INSTRUCTION FOR THE SPECIALIST.
Description of the drug approved by the manufacturer for the printed edition of 2015.
PHARMACHOLOGIC EFFECT
Keratoprotective agent. The carbomer is a high molecular weight polymer and is a combination of polyacrylic acid and water as a dispersion medium. It promotes the replacement of the aqueous and mucin layers of the tear film, increases the viscosity of the tear, forming a protective moisturizing film on the surface of the cornea.
PHARMACOKINETICS
Due to its physico-chemical properties, Lakropos gel remains on the surface of the eye for a long time, and does not penetrate into the tissues of the eye. The carbomer is not resorbed and deposited in tissues due to the high molecular weight of the carbomer molecule.
INDICATIONS
As a liquid solder:
- with a violation of the production of tears;
- with dry eye syndrome.
DOSING MODE
Bury 1 drop of gel in the conjunctival sac 3-5 times / day and about 30 minutes before bedtime.
The frequency of instillation of the gel is determined individually, depending on the severity of the clinical picture and according to the recommendations of the doctor. If necessary, Lakropos can be digested more often.
It is recommended to distribute gel applications evenly throughout the day.
In cases requiring long-term therapy, you should consult an ophthalmologist.
Mode of application
Throw your head back a little, with your index finger slightly to remove the lower eyelid. Holding the tube in the vertical position above the level of the eye (without touching the eye surface) with the other hand, drip 1 drop of gel into the conjunctival sac. After instillation, slowly follow the eyes in different directions for better distribution of the gel. Then gently close your eyes.
When instilled, avoid contact between the tip of the tube and the surface of the eye and eyelid. After the procedure is finished, put a protective cap on the tube.
Removing the eye gel from the tube should be carefully pressed, without crushing or twisting the tube.
SIDE EFFECT
From the side of the eye: in rare cases - hypersensitivity reactions to one of the components in the drug, allergic reactions, transient visual impairment.
Lacropos gel contains cetrimide as a preservative, which can cause eye irritation (for example, burning, redness, foreign body feeling), as well as damage to the corneal epithelium, mainly during prolonged therapy.
CONTRAINDICATIONS
- wearing soft contact lenses;
- children and adolescence under 18;
- Hypersensitivity to the components of the drug.
PREGNANCY AND LACTATION
Adequate strictly controlled clinical trials of the drug with the participation of pregnant women were not conducted.
During pregnancy and during lactation, it is possible to use the drug only after a careful evaluation by the doctor of the expected benefit of therapy for the mother and the possible risk to the fetus or infant.
SPECIAL INSTRUCTIONS
With the simultaneous use of several eye medicines, Lakropos should be instilled last, not earlier than 15 minutes after the use of eye drops.
Lacropos gel should not be used when wearing soft contact lenses. Before instillation of the drug, hard contact lenses should be removed and reinstalled 15-30 minutes after instillation of the drug.
Impact on the ability to drive vehicles and manage mechanisms
Immediately after instillation of the eye gel, Lacropos may have a brief disturbance of visual acuity, leading to a slowing of mental and physical reactions. Therefore, it is not recommended to apply the drug directly before working with mechanisms and driving vehicles. Within 30 minutes after instillation, it is necessary to refrain from occupations that require increased attention.
OVERDOSE
No cases of an overdose of Lacropos have been reported.
DRUG INTERACTION
Interaction with other drugs has not been studied.
Lakropos gel can prolong the action of other ophthalmic drugs with simultaneous application.
TERMS OF RELEASE FROM PHARMACY
The drug is approved for use as a means of OTC.
TERMS AND CONDITIONS OF STORAGE
The drug should be stored out of reach of children at a temperature of no higher than 25 В° C. Shelf life in closed original packaging is 3 years.
After opening the tube, use within 4 weeks.
Do not use after the expiration date printed on the package.
